Clinical implications of subclonal TP53 mutations in acute myeloid leukemia

The role of subclonal TP53 mutations, defined by a variant allele frequency of <20%, has not been addressed in acute myeloid leukemia yet. We, therefore, analyzed their prognostic value in a cohort of 1,537 patients with newly diagnosed disease, prospectively treated within three trials of the “G...

Descripción completa

Detalles Bibliográficos
Autores principales: Prochazka, Katharina T., Pregartner, Gudrun, Rücker, Frank G., Heitzer, Ellen, Pabst, Gabriel, Wölfler, Albert, Zebisch, Armin, Berghold, Andrea, Döhner, Konstanze, Sill, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395341/
https://www.ncbi.nlm.nih.gov/pubmed/30309854
http://dx.doi.org/10.3324/haematol.2018.205013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395341/
https://www.ncbi.nlm.nih.gov/pubmed/30309854
http://dx.doi.org/10.3324/haematol.2018.205013

Ejemplares similares